Financials
Financial year 2026
The BioPharmaTechnology House from Meerhout, company number BE0866427061, closed financial year 2026 with a result of € 169,837 after tax. For that financial year The BioPharmaTechnology House recorded a gross margin of € 320,612 and equity of € 639,081. Compared with financial year 2025, the result moved from € 20,100 to € 169,837. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2026.
€ 639,081
▲ 36% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 169,837
▲ € 149,737 vs 2025
Profit after tax over the fiscal year.
€ 110,198
▼ 24% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 1,666 paid out
1 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2026
€ 739
▼ 85% vs 2025
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 20,362
▼ 32% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
€ 17,125
▼ 35% vs 2025
€ 9,248 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 14,193
▲ 16% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 54,840
▲ 110% vs 2025
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 82,312 | € 133,005 | € 120,502 | € 320,612 | ▲ 166% |
| Profit after taxes | € -5,582 | € -3,846 | € 20,100 | € 169,837 | ▲ € 149,737 |
| Equity | € 458,041 | € 452,528 | € 470,910 | € 639,081 | ▲ 36% |
| Total debts | € 219,915 | € 221,302 | € 223,451 | € 293,424 | ▲ 31% |
| Cash | € 179,025 | € 55,398 | € 144,723 | € 110,198 | ▼ 24% |
| Land & buildings | € 415,099 | € 378,282 | € 342,222 | € 307,661 | ▼ 10% |
| Retained profit | € 439,441 | € 433,928 | € 452,310 | € 620,481 | ▲ 37% |
| Dividend | € 0 | € 1,666 | € 1,718 | € 1,666 | ▼ 3% |
| Bank debt | € 58,318 | € 39,952 | € 26,176 | € 17,125 | ▼ 35% |
| Balance sheet total | € 677,956 | € 673,830 | € 694,361 | € 932,505 | ▲ 34% |
By gross margin, The BioPharmaTechnology House ranks 1st of 19 companies with main activity “Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten” in Meerhout that publish figures (fiscal year 2026).
Key figures of The BioPharmaTechnology House, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.
Ask about The BioPharmaTechnology House the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to The BioPharmaTechnology House?
What happened at The BioPharmaTechnology House in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 169,837 (▲ € 149,737 vs 2025). Source: NBB ↗
- New establishment in Meerhout. KBO
- Start of the company according to the CBE. KBO
In short
From € 5,582 loss in 2023 to € 169,837 profit in 2026.
Paid € 101,582 in corporate taxes since 2023.
Best year ever: 2026, with € 169,837 profit.
Paid out € 5,050 in dividends to the owners in total.
Management
Behind The BioPharmaTechnology House are Veerle VAN DEN BRANDE and Mario PEETERS.
Directors
According to the 2026 annual accounts
Veerle VAN DEN BRANDE
Director
Mario PEETERS
Director
Establishments
Establishment units
Physical locations of this company
De Biezen 22
2450 Meerhout
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Meerhout
Same main activity (Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten), 25 active companies in Meerhout, largest first.
€ 175,281 gross margin · 2025
€ 124,270 gross margin · 2025
€ 104,282 gross margin · 2025
€ 96,447 gross margin · 2025
€ 85,724 gross margin · 2025
€ 78,220 gross margin · 2025
Website
Technologies
Hosting & Email
Email provider
Outlook.com (free)
Hosting
COMBELL-AS, BE
Domain
Domain
bpth.com
Registered
2004-06-11
Registrar
Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Expires
2026-06-11
Website info
Features
Security
Details
- Company number
- 0866.427.061
- VAT number
- BE 0866.427.061
- Registered office
- De Biezen 22, 2450 Meerhout
- Names & denominations
- The BioPharmaTechnology House
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 July 2004
- Peppol
- Active · Active since 1 Oct 2025
- Contact
- bpth.com [email protected]
- Activities · NACE
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Computeradviesbureaus
Computerconsultancy-activiteiten
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten
Handelsbemiddeling in de groothandel in machines, apparaten en werktuigen voor de industrie en in schepen en luchtvaartuigen
Activiteiten van interieurarchitecten
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Technische studiën en ingenieursactiviteiten
+3